本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Checkpoint Therapeutics, Inc.

4.26
0.0000
成交量:- -
成交額:3,686.13萬
市值:3.57億
市盈率:-3.48
高:4.26
開:4.26
低:4.26
收:4.26
資料載入中...
2025/05/30

交易所摘牌聲明

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2025/05/30

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/05/30

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/05/30

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/05/30

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/05/30

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/05/30

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/05/30

重要事件披露

Form 8-K - Current report
2025/05/29

重要事件披露

Form 8-K - Current report
2025/05/22

重要事件披露

Form 8-K - Current report
2025/05/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/13

重要事件披露

Form 8-K - Current report
2025/04/15

重要事件披露

Form 8-K - Current report
2025/03/28

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/28

重要事件披露

Form 8-K - Current report
2025/03/10

重要事件披露

Form 8-K - Current report
2025/01/10

重要事件披露

Form 8-K - Current report
2024/12/16

重要事件披露

Form 8-K - Current report
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]